TransMedics Group Inc.

NASDAQ: TMDX · Real-Time Price · USD
126.98
1.33 (1.06%)
At close: Aug 19, 2025, 10:22 AM

TransMedics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
336.65M 394.81M 201.18M 25.58M
Short-Term Investments
n/a n/a n/a 66.87M
Long-Term Investments
n/a n/a 500K 500K
Other Long-Term Assets
708K 562K n/a n/a
Receivables
97.72M 63.58M 27.61M 5.93M
Inventory
46.55M 44.23M 20.61M 14.86M
Other Current Assets
16.29M 8.03M 2.9M 5.46M
Total Current Assets
497.22M 510.65M 252.29M 118.7M
Property-Plant & Equipment
292.45M 180.49M 24.35M 15.69M
Goodwill & Intangibles
13.7M 14.34M n/a n/a
Total Long-Term Assets
306.86M 195.39M 24.85M 16.19M
Total Assets
804.08M 706.05M 277.15M 134.89M
Account Payables
10.29M 12.72M 3.34M 6.65M
Deferred Revenue
1.74M 1.96M 241K 250K
Short-Term Debt
2.73M n/a 1.44M n/a
Other Current Liabilities
45.15M 17.92M 7.38M 11.16M
Total Current Liabilities
59.91M 54.93M 23.66M 23.24M
Long-Term Debt
509.31M 506.2M 58.7M 35.2M
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
515.56M 513.91M 66.11M 43.8M
Total Liabilities
575.47M 568.85M 89.77M 67.04M
Total Debt
518.29M 515.95M 67.56M 8.6M
Common Stock
697.21M 641.11M 666.28M 510.49M
Retained Earnings
-468.24M -503.7M -478.68M -442.45M
Comprehensive Income
-364K -199K -225K -188K
Shareholders Equity
228.6M 137.2M 187.38M 67.85M
Total Investments
n/a 500K 500K 66.87M